Clinical trial
Study of SS1(dsFv)-PE38 (SS1P) Anti-Mesothelin Immunotoxin in Advanced…
NCT00024674 · INSYS Therapeutics Inc, Industry · Withdrawn
Key facts
| NCT number | NCT00024674 |
|---|---|
| Title | Study of SS1(dsFv)-PE38 (SS1P) Anti-Mesothelin Immunotoxin in Advanced Malignancies: Continuous Infusion for 10 Days |
| Lead sponsor | INSYS Therapeutics Inc, Industry |
| Status | Withdrawn |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Neoplasms |
| Intervention type | Drug |
| Interventions | SS1(dsFv)-PE38 |
| Enrollment | 0 |
| Start date | Feb 1, 2001 |
| First posted | Sep 25, 2001 |
| Last update posted | Nov 14, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: